Literature DB >> 12925063

Use of insulin glargine during embryogenesis in a pregnant woman with Type 1 diabetes.

A Holstein, A Plaschke, E-H Egberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12925063     DOI： 10.1046/j.1464-5491.2003.00992.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

Review 1.  Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.

Authors:  Celeste P Durnwald; Mark B Landon
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

2.  The insulin analog glargine during an unplanned pregnancy.

Authors:  Daniela Cechurová; Silvie Lacigová; Zdenĕk Jankovec; Iva Haladová; Michal Zourek; Michal Krcma; Zdenĕk Rusavý; Jirí Turek
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

3.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

Review 4.  Insulin glargine in the treatment of type 1 and type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2006

5.  Perinatal outcomes associated with the use of glargine during pregnancy.

Authors:  G Di Cianni; E Torlone; C Lencioni; M Bonomo; A Di Benedetto; A Napoli; E Vitacolonna; D Mannino; A Lapolla
Journal:  Diabet Med       Date:  2008-08       Impact factor: 4.359
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.